ICU MEDICAL INC (ICUI) Stock Analyst Earnings Estimates
NASDAQ:ICUI - Nasdaq - US44930G1076 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.316B 3.56% | 2.28B 73.21% | 2.259B -0.92% | 2.358B 4.38% | 2.366B 0.34% | 2.437B 3.00% | 2.326B -4.55% | 2.406B 3.44% | |
| EBITDA YoY % growth | 231.1M 9.42% | 263.7M 14.11% | 292.857M 11.06% | 367.9M 25.62% | 412.76M 12.19% | 448.32M 8.62% | 457.67M 2.09% | 504.46M 10.22% | |
| EBIT YoY % growth | 141.4M 12.58% | 28.5M -79.84% | 64.083M 124.85% | 284.97M 344.69% | 327.36M 14.88% | 343.42M 4.91% | N/A | N/A | |
| Operating Margin | 10.74% | 1.25% | 2.84% | 12.09% | 13.84% | 14.09% | N/A | N/A | |
| EPS YoY % growth | 7.39 3.65% | 6.54 -11.50% | 6.76 3.36% | 5.71 -15.48% | 7.27 27.28% | 8.71 19.78% | 10.74 23.30% | 13.04 21.37% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 1.51 -3.52% | 1.43 49.46% | 1.77 13.77% | 1.83 15.04% | 2.03 33.78% | 1.72 20.04% | 2.15 20.86% | 2.23 22.04% | 2.40 18.64% |
| Revenue Q2Q % growth | 606.83M 5.40% | 586.04M 6.05% | 616.95M 6.19% | 616.44M 4.64% | 633.78M 4.44% | 602.11M 2.74% | 636.07M 3.10% | 635.26M 3.05% | 651.88M 2.86% |
| EBITDA Q2Q % growth | 97.189M -57.25% | 91.851M 50.63% | 103.79M -23.50% | 104.35M -45.53% | 112.2M 15.45% | 98.022M 6.72% | 117.4M 13.11% | 119.65M 14.66% | 126.48M 12.73% |
| EBIT Q2Q % growth | 74.868M 5,256.20% | 64.974M 1,092.18% | 82.008M 230.30% | 86.292M 244.29% | 92.514M 23.57% | 76.602M 17.90% | 95.37M 16.29% | 97.206M 12.65% | 103.63M 12.02% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 1.59 1.27% | 1.28 | 0.31 | 24.67% |
| Q2 2024 Q2Q % growth | 1.56 -17.02% | 1.02 | 0.54 | 53.22% |
| Q1 2024 Q2Q % growth | 0.96 -44.83% | 0.84 | 0.12 | 14.78% |
| Q4 2023 Q2Q % growth | 1.57 -1.88% | 1.22 | 0.35 | 29.07% |
| Q3 2023 Q2Q % growth | 1.57 -10.29% | 1.41 | 0.16 | 11.13% |
| Q2 2023 Q2Q % growth | 1.88 37.23% | 1.63 | 0.25 | 15.20% |
| Q1 2023 Q2Q % growth | 1.74 -4.40% | 1.46 | 0.28 | 19.57% |
| Q4 2022 Q2Q % growth | 1.60 -12.09% | 1.59 | 0.01 | 0.55% |
| Q3 2022 Q2Q % growth | 1.75 -15.46% | 1.49 | 0.26 | 17.25% |
| Q2 2022 Q2Q % growth | 1.37 -27.13% | 1.69 | -0.32 | -19.09% |
| Q1 2022 Q2Q % growth | 1.82 12.35% | 1.82 | 0.00 | 0.06% |
| Q4 2021 Q2Q % growth | 1.82 2.82% | 1.68 | 0.14 | 8.58% |
| Q3 2021 Q2Q % growth | 2.07 8.95% | 1.83 | 0.24 | 12.95% |
| Q2 2021 Q2Q % growth | 1.88 13.94% | 1.67 | 0.21 | 12.39% |
| Q1 2021 Q2Q % growth | 1.62 -10.50% | 1.53 | 0.09 | 5.65% |
| Q4 2020 Q2Q % growth | 1.77 -8.76% | 1.54 | 0.23 | 14.92% |
| Q3 2020 Q2Q % growth | 1.90 15.15% | 1.33 | 0.57 | 42.56% |
| Q2 2020 Q2Q % growth | 1.65 -17.09% | 1.26 | 0.39 | 30.46% |
| Q1 2020 Q2Q % growth | 1.81 -29.84% | 1.66 | 0.15 | 9.09% |
| Q4 2019 Q2Q % growth | 1.94 | 1.66 | 0.28 | 16.68% |
| Q3 2019 Q2Q % growth | 1.65 | 1.65 | 0.00 | 0.06% |
| Q2 2019 Q2Q % growth | 1.99 | 2.10 | -0.11 | -5.14% |
| Q1 2019 Q2Q % growth | 2.58 | 2.21 | 0.37 | 16.74% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 589.131M 7.78% | 586.19M | 2.941M | 0.50% |
| Q2 2024 Q2Q % growth | 580.982M 8.57% | 564.77M | 16.212M | 2.87% |
| Q1 2024 Q2Q % growth | 552.582M -0.61% | 563.3M | -10.718M | -1.90% |
| Q4 2023 Q2Q % growth | 575.744M -0.39% | 574.29M | 1.454M | 0.25% |
| Q3 2023 Q2Q % growth | 546.615M -8.58% | 577.07M | -30.455M | -5.28% |
| Q2 2023 Q2Q % growth | 535.112M -4.61% | 579.9M | -44.788M | -7.72% |
| Q1 2023 Q2Q % growth | 555.946M 2.37% | 576.61M | -20.664M | -3.58% |
| Q4 2022 Q2Q % growth | 578M 69.75% | 590.34M | -12.34M | -2.09% |
| Q3 2022 Q2Q % growth | 597.9M 77.89% | 576.3M | 21.6M | 3.75% |
| Q2 2022 Q2Q % growth | 561M 74.39% | 571.13M | -10.13M | -1.77% |
| Q1 2022 Q2Q % growth | 543.1M 70.79% | 564.23M | -21.13M | -3.74% |
| Q4 2021 Q2Q % growth | 340.5M 6.24% | 326.3M | 14.2M | 4.35% |
| Q3 2021 Q2Q % growth | 336.1M 5.49% | 320.59M | 15.51M | 4.84% |
| Q2 2021 Q2Q % growth | 321.7M 6.03% | 311.54M | 10.16M | 3.26% |
| Q1 2021 Q2Q % growth | 318M -3.23% | 306.92M | 11.08M | 3.61% |
| Q4 2020 Q2Q % growth | 320.5M 1.58% | 301.24M | 19.26M | 6.39% |
| Q3 2020 Q2Q % growth | 318.6M 3.61% | 290.39M | 28.21M | 9.71% |
| Q2 2020 Q2Q % growth | 303.4M -2.85% | 282.23M | 21.17M | 7.50% |
| Q1 2020 Q2Q % growth | 328.6M -0.70% | 302.23M | 26.37M | 8.73% |
| Q4 2019 Q2Q % growth | 315.5M | 301.61M | 13.89M | 4.61% |
| Q3 2019 Q2Q % growth | 307.5M | 296.99M | 10.51M | 3.54% |
| Q2 2019 Q2Q % growth | 312.3M | 315.32M | -3.02M | -0.96% |
| Q1 2019 Q2Q % growth | 330.9M | 325.35M | 5.55M | 1.71% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -5.11% | 0% | 7.94% |
| Revenue | 0% | -0.06% | 0% | 0.55% |